Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2019

Apr 3, 2019

34491_dirs_2019-04-03_b2cc2435-8235-4c04-b1da-f02c3c6c3751.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-04-01

Reporting Person: FMR LLC (See Remark 1)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-04-01 Common Stock C 3279170 Acquired 3279170 Indirect
2019-04-01 Common Stock C 409078 Acquired 3688248 Indirect
2019-04-01 Common Stock P 50000 $16 Acquired 3738248 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-04-01 Series A Preferred Stock $ C 7000000 Disposed Common Stock (3279170) Indirect
2019-04-01 Series B Preferred Stock $ C 873253 Disposed Common Stock (409078) Indirect

Footnotes

F1: On April 1, 2019, in connection with the completion of the issuer's initial public offering, each 2.134686 shares of Series A Preferred Stock and Series B Preferred Stock converted into 1 share of Common Stock.